首页> 外文期刊>The Lancet >SPACE: not the final frontier.
【24h】

SPACE: not the final frontier.

机译:空间:不是最终的疆界。

获取原文
获取原文并翻译 | 示例
           

摘要

The 2005 Cochrane review of randomisedtrials comparing carotid endarterectomy with carotid angioplasty and stenting concluded that the evidence did not support a "widespread change in practice from recommending carotid endarterectomy as the treatment of choice" in patients with carotid disease.In today's Lancet, SPACE becomes the eighth randomised trial to be published2 and its sample size of 1200 will double the number of patients in the Cochrane database. So will SPACE lead to a change in recommendations after the next review?The methods in SPACE were different from those of its predecessors. In the traditional randomised trial, the null hypothesis assumes no difference between two interventions. The investigators then hope to reject the null hypothesis and show a clinically significant difference (a superiority trial). SPACE, however, aimed to show non-inferiority-ie, carotid angioplasty and stenting was no worse than carotid endarterectomy.3 In this type of study, a predetermined margin of non-inferiority is defined from the outset whose value will reflect the power calculation, the likely magnitude of risk to be encountered, and an allowance for whether a slightly increased procedural risk after carotid angioplasty and stenting might be offset by other important benefits (eg, no incision, no cranial nerve injury). In SPACE, the predefined limit for non-inferiority was that the upper confidence interval (CI) for the actual difference in the primary endpoint should be less than 2.5%. With intention-to-treat analysis, the actual difference was 0.51% (90% CI -1.89 to 2-91). In a per-protocol analysis, the actual difference was 1.32% (-110 to 3.76). The figure illustrates these findings in the context of the margin of non-inferiority. If carotid angioplasty and stenting was non-inferior (ie, as good as carotid endarterectomy), the upper CI would be less than 2.5 and within the shaded box. In both methods of analysis, however, the upper CI is more than 2.5, which shows that non-inferiority was not achieved. However, because the CI crosses zero, the difference is non-significant or uncertain. In other words, surgeons will conclude that carotid angioplasty and stenting was inferior to carotid endarterectomy, although interventionists will conclude that there was no significant difference.
机译:在2005年的Cochrane对颈动脉内膜切除术与颈动脉血管成形术和支架置入术进行比较的随机试验中,得出结论认为,证据不支持“在颈动脉疾病患者中将颈动脉内膜切除术作为首选治疗方法的广泛改变”。第八项随机试验即将发表2,其样本量为1200,将使Cochrane数据库中的患者人数增加一倍。那么SPACE在下次审核后是否会导致建议的更改?SPACE中的方法与以前的方法不同。在传统的随机试验中,无效假设假设两种干预措施之间没有差异。然后,研究人员希望拒绝原假设,并显示出临床上的显着差异(优势试验)。但是,SPACE旨在显示非自卑性,即颈动脉血管成形术和支架置入术不比颈内动脉内膜切除术差。3在这种类型的研究中,从一开始就定义了预定的非自卑边缘,其值将反映功效计算,可能遇到的风险大小以及在颈动脉血管成形术和支架置入术后是否略微增加手术风险的准备金可能会被其他重要好处(例如,无切口,无颅神经损伤)所抵消。在SPACE中,非劣势性的预定义极限是主要终点的实际差异的上限置信区间(CI)应小于2.5%。通过意向性治疗分析,实际差异为0.51%(90%CI -1.89至2-91)。在每个协议的分析中,实际差异为1.32%(-110至3.76)。该图在非自卑的边缘说明了这些发现。如果颈动脉血管成形术和支架置入术不劣(即与颈动脉内膜切除术一样好),则上CI值应小于2.5,并位于阴影框内。但是,在两种分析方法中,最高CI均大于2.5,这表明未实现自卑感。但是,由于CI跨过零,因此差异不明显或不确定。换句话说,尽管介入医师会得出结论,两者之间没有显着差异,但外科医生会得出结论认为,颈动脉血管成形术和支架置入术不如颈动脉内膜切除术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号